Studies on the reversion characteristics of Escherichia coli strains carrying various mutations in the pts region have led to the recognition of a mutation, suc-1, with a previously undescribed phenotype. Strains carrying the suc-1 mutation grow normally on most sources of carbon but are unable to utilize succinate effectively. The suc-1 mutation can be separated genetically from the tightly linked ptsI6 mutation. Reversion of suc-1 mutants for growth on succinate yields interesting classes of suppressor mutations.
The bacterial phosphoenolpyruvate (PEP): sugar phosphotransferase system (PTS system) phosphorylates specific sugars (termed PTS sugars) via the following overall reactions (7):
PEP + HPr enizyme I-HPr -P + pyruvate HPr -P + sugar enzyme I 4 sugar-P + HPr Mutants defective in enzyme I or HPr differ from wild-type strains in that they are unable to utilize effectively as a source of carbon any specific PTS sugars such as glucose, fructose, mannose, or mannitol. This observation is not surprising since the phosphorylation reaction carried out by the PTS system usually constitutes the first step in the catabolism of PTS sugars. In addition, Roseman (7) has presented evidence that the PTS system is necessary for the actual transport of PTS sugars across the cell membrane.
It is of interest that cells carrying a mutation in the gene for PTS enzyme I (ptsf) usually fail to grow well on many compounds that do not require phosphorylation by the PTS system in order to be metabolized. Thus it appears that the utilization of non-PTS compounds can be dependent on the PTS system, even though these compounds are not necessarily phosphorylated by this system. However, in contrast to the situation with PTS sugars, the ability of a ptsI mutant to utilize a particular non-PTS compound depends upon the specific mutation affecting enzyme I and upon the genetic background in I Present address: Department of Biological Chemistry, Hahnemann Medical College, Philadelphia, Pa. 19102. which this pts mutation is expressed. For example, Berman et al. (1) have shown for one ptsI mutant that does not grow on glycerol that introduction of additional mutations affecting the degradative pathway for glycerol can restore the ability of this ptsl mutant to utilize glycerol specifically. Similarly, it has been observed (11) that mutations in the lac regulatory gene can alter the utilization of lactose in ptsI strains. Thus an accumulation of pathway-specific mu- tations in a strain can dramatically affect the impact of a ptsI mutation on the strain's ability to utilize non-PTS compounds, and this interaction may be the explanation for the effect of strain background on the utilization of non-PTS compounds by ptsI strains.
All known pts mutants do grow at wild-type rates, regardless of strain background, on certain non-PTS compounds such as gluconate and glucose-6-phosphate. It is not known why pts mutants should respond differently to these two non-PTS compounds.
The present work is concerned with the utilization of a particular non-PTS compound, succinate, by Escherichia coli ptsI mutants and their revertants.
MATERIALS AND METHODS
Bacterial strains. The strains of E. coli are listed in Table 1 .
Media. LB and OM agar have been described (4 Determination of substrate utilization. The ability to grow on OM medium containing a specific substrate was used as the criterion for utilization of that substrate. Usually fresh inoculum was taken from an LB plate with an applicator stick or a toothpick and transferred to a series of plates containing different substrates. Growth of ptsI mutants, revertants, and transductants was always evaluated in relation to the growth of a wild-type strain on the same plate. Strains that failed to grow significantly within 24 h after the wild-type strain had obtained full growth at 37 C were scored as negative.
Transductions. Transductions were carried out by the procedures described previously (10) . For the selection of streptomycin-resistant transductants, 1 ml of 1 M sodium citrate and 5 ml of molten LB agar were added to the transduction mixture after absorption of the transducing phage. This mixture was poured over an LB plate and incubated for 3 h at 37 C. At this time, 3 ml of molten LB agar containing streptomycin (1.3 mg/ml) was added and the plates were incubated for 2 or 3 days at 37 C.
Preparation of a purC ptsI6 suo-I strain. A purC ptsI6 suc-i strain was prepared by a transduction in which the donor (strain A106) harbored the ptsI and suC mutations of strains MM6 and the recipient was a purC mutant (CHE-25). Transductants were selected on LB agar containing 5 mg of fosphonomycin per liter (obtained from Merck). Strain CHE-25 is inhibited by this concentration of fosphonomycin whereas strain A106 is not. The resistance of A106 presumably is due to the lack of activity of the a-glycerophosphate permease which is required for the uptake of fosphonomycin. Thus, the selection was based on resistance of ptsI transductants to fosphonomycin. A typical transductant, strain 16, requires purine and is unable to utilize either PTS or non-PTS substrates. The possibility that strain 16 is a ptsI mutant of CHE-25 rather than a transductant was ruled out by examination of revertants selected on mannitol. The revertants of strain 16 and MM6 selected on mannitol were similar in that they utilized PTS sugars but remained Suc-. When revertants of other ptsI mutants were selected on mannitol, they utilized both PTS sugars and succinate (see Table 4 ).
RESULTS
Growth properties of strain MM6. E. coli K-12 strain MM6 has been characterized as carrying a mutation affecting enzyme I of the PTS system (9) . The growth characteristics of strain MM6 ( (Pts-) . Similarly, revertants selected on mannitol, fructose, or mannose regained the ability to grow on all PTS sugars (i.e., became Pts+) but did not simultaneously regain the ability to utilize succinate.
Further study showed that the Pts+ Suc-revertants were able to regain the ability to utilize succinate if selected for growth on succinate minimal medium. Likewise, after reversion of MM6-12 (Suc+ Pts-) on mannitol, the resulting double revertant MM6-12M was Suc+ Pts+. Thus, in regard to utilization of PTS sugars and succinate, the double revertants resembled strain 3300, the parent strain of MM6.
We have examined over 500 independent revertants of strain MM6, selected on a PTS sugar or succinate, and have never encountered a single-step reversion in strain MM6 that restores its ability to utilize both PTS sugars and succinate. These observations might imply that strain MM6 has two mutations, one that prevents the utilization of PTS sugars and another that prevents the utilization of succinate.
Genetic analysis of strain MM6. During the course of this investigation, Lo et al. (5) reported that they also found that strain MM6 reverts to either the Pts+ Suc-or Pts-Suc+ phenotype. They concluded that the inability of strain MM6 to utilize succinate is due to a mutation in the dicarboxylic acid transport system (dctB-) linked to the gal operon rather than to a deficiency in enzyme I. It seemed to us unlikely that a Suc-phenotype due to a dctBmutation could be reversed by cAMP, and our Suc-isolate of strain MM6 certainly became Suc+ in the presence of cAMP.
Therefore, to clarify this inconsistency we repeated the transductions which, according to Lo et al. (5) , had shown that the mutation resulting in the Suc-phenotype is linked to the gal locus on the E. coli chromosome. A galactose-negative mutant, strain EG47, was transduced with phage grown on strain MM6 (Table   3 A wild-type (Suc+ Pts+) strain, 3300, served as the donor for phage P1-mediated transduction of strain MM6 (Pts-Suc-), and transductants were selected for growth on PTS sugars or for growth on succinate. From the results in Table 3 it appears that the mutation(s) resulting in the Suc-and Pts-phenotype was highly cotransducible. All of the transductants selected on mannitol or fructose regained the ability to grow on succinate. Similarly, all of the transductants selected on succinate regained the ability to grow on PTS sugars. The results of these transductions seem to indicate that the lesion causing the Suc-phenotype is tightly iinked to the ptsI mutation in strain MM6. In view of this linkage, one would predict that upon introduction of the pts region from strain MM6 into a previously wild-type strain, it would become both Pts-and Suc-and, if two separate tightly linked mutations cause the Pts-Suc-phenotype, then this strain also should be unable to revert to the wild-type phenotype in a single step. In addition, the lesion causing the Suc-phenotype in the Pts+ Suc-revertants of strain MM6 should also be transduced with the pts genes.
The ptsI gene has been mapped near the purC locus (3) in E. coli. Therefore, to test these predictions, P1 grown on strain MM6 was used to transduce strain A100, a purC mutant, and transductants were selected on purine-free gluconate medium (Table 3 ). In agreement with the results of Epstein et al. (3) , 4% of the transductants acquired the ptsI-mutation of strain MM6 as evidenced by their inability to grow on mannitol. All of these ptsI transductants were also unable to grow on succinate as a source of carbon (Table 3) .
When P1 grown on a Pts+ Suc-revertant (strain MM6-1) of strain MM6 were used for this transduction, all of the purC+ transductants were Pts+ (able to grow on mannitol), but again 6% of these purC+ transductants had acquired the Suc-phenotype. This result indicates that the reversions to Pts+ in strain MM6-1 occurred at the ptsI site but did not affect a tightly linked mutation that still elicited the Suc-phenotype.
Reversion characteristics of ptsl mutants. The observation that transductants of strain A100 carrying the pts region of strain MM6 are unable to grow on succinate is not surprising in itself since we found ( Table 4 ) that other ptsI mutants in the same strain background were also unable to grow on succinate. However, the observation that the lesion resulting in the Succharacter of a Pts+ Suc-revertant of strain MM6 (strain MM6-1) is also cotransduced with purC is clearly consistent with the idea that strain MM6 carried two tightly linked mutations, one resulting in a "classical" ptsI phenotype and another affecting growth on the non-PTS compound succinate.
To test this idea we examined the reversion pattern of strain A106, a Suc-Pts-transductant of strain A100 carrying the pts region of strain MM6. The results in Table 4 clearly show the contrast between the reversion pattern of strain A106 and those of strains carrying the ptsI211 and ptsI40 mutations in the same strain background. Every revertant of A211 (ptsI211) and A240 (ptsI40) selected for growth on a PTS VOL. 124, 1975 on January 18, 2018 by guest http://jb.asm.org/ The results of several other crosses support the notion that strain A106 harbors two ptslinked mutations. One example is the transduction of strain 16 (PurC-Pts-Suci) carrying the pts region from strain A106. Phage grown on strain 1101' (purC+ ptsH) were used and recombinants were selected on purine-free fructose minimal medium. In this case simultaneous selection for two weakly linked genes (purC and ptsI) should tend to increase their separation from genes distal to the coselected segment and dramatically increase co-inheritance of genes lying within the coselected segment, purC ptsI.
As shown in Table 5 , the co-inheritance of the ptsH gene with the purC ptsI segment was only 95%, compared with more than 98% when ptsI alone was the selected marker. Thus these results argue that the gene order in this region is purC ptsI ptsH, which agrees with the conclusions of Epstein et al. (3) . This cross also succeeded in separating the Pts and Suc phenotypes since PurC + Pts+ Suc -recombinants were recovered.
A control experiment was performed to be sure that the rather small number of colonies scored as PurC+ Pts+ Suc-were true recombinants formed during transduction of the pts region rather than purC transductants that had reverted to the Pts+ Suc-phenotype. The relative efficiency of transduction for P1 lysates from a wild-type donor (strain 1100) and from strain A106 (ptsI6 suc-i) was determined by selecting PurC + transductants of strain 16 (purC-ptsI6 suc-1) on gluconate medium. Then cells of strain 16, infected with one of these lysates, were plated on mannitol minimal medium to select for PurC+ and Pts+ transductants. In each case, the same relative number of P1-infected cells, normalized for transduction efficiency of the lysate, was examined. When strain A106 served as the donor no colonies appeared on the selection plates. However, when the wild-type strain, 1100, served as the donor, PurC + Pts+ transductants were obtained, and 0.7% of these were PurC+ Pts+ Suc- (Table 5 ).
This experiment indicates that, after transduction to PurC+, strain 16 does not revert on mannitol minimal medium plates to Pts+. Therefore the recovery of PurC+ Pts+ Sucrecombinants from strain 16 infected with P1 grown on a wild-type donor strongly suggests that this strain harbors a mutation specifically responsible for the Suc-phenotype. In addition this experiment indicates that, in relation to purC, this suc-1 mutation is distal to another mutation, ptsI6, affecting the Pts phenotype.
When selection was for simultaneous inheritance by strain 16 of purC and suc characters from strain 1100, then all of the transductants had the Pts+ phenotype. However, selection for the Suc+ phenotype should yield this result, regardless of the map position of the suc-i lesion, if the ptsI6 and suc-i result in the Sucphenotype. Nevertheless, the data from Table  5 , taken together with those from transduction of strain A106 with phage grown on the ptsH mutant 1101', suggest the order purC ptsI suc ptsH.
Mucoidy and the inability to utilize succinate. Suc-derivatives of strain CHE-25 formed mucoid colonies on galactose medium at 37 C (Table 4 ). This property of mucoidy on galactose appears to be dependent on both the genetic background and the inability to utilize succinate.
Strain MM6 (Pts-Suc-), which was derived from strain 3300, did not become mucoid on galactose, but strain A106 (Pts-Suci), which carried the pts region of strain MM6 in the background of strain CHE-25, formed mucoid colonies on galactose. Within the background of strain CHE-25, the mucoid phenotype correlated completely with the Suc-phenotype. Thus Suc-derivatives of strain CHE-25 carrying only a "classical" ptsI mutation such as ptsI40 or ptsI211 are mucoid on galactose and Pts+ Suc-revertants of strain A106 are also mucoid on galactose. The Suc+ parental strain, Suc+ revertants, and Suc+ transductants of these strains all formed normal colonies on galactose.
Mapping of Suc+ revertants. The transductions in Table 6 were carried out to examine the possibility that reversions to Suc+ are linked to the ptsI site. The rationale for the experiment was based on the observation that, in every case we examined, the site of reversion of a ptsI mutant to the Pts+ phenotype appeared to occur at the ptsI locus. From this it follows that, if a Pts-Suc-strain becomes Suc+ by a mutation linked to the ptsI locus, then the site of this Suc+ reversion will be linked during transduction to any mutation in this strain that restored the Pts+ character. On the other hand, if the site of reversion to the Suc+ phenotype is a Denotes the number of mucoid colonies an unlinked suppressor mutation, then the Suc+ phenotype will not be cotransduced with reversions restoring the Pts+ character to the strain.
The transductions in Table 6 , lines 1 and 2, illustrate this procedure. Strain A106-1 (Pts+ Suc-) was selected from strain A106 (PtsSuc-) on mannitol medium, and the mutation responsible for restoration of the PTS+ phenotype was found to be 4% linked to purC (data not shown). Independent revertants of strain A106-1 (Pts+ Suc-) were subsequently selected for growth on succinate. One of these double revertants, strain A106-1S (Pts+ Suc+), and the single revertant, strain A106-1 (Pts+ Suc), were then crossed back into the original PtsSuc-strain, A106, by phage P1-mediated transduction. Transductants with the Pts+ character were selected on mannitol medium. As expected, when strain A106-1 (Pts+ Suci) served as the donor, all of the Pts+ transductants were Suc-and formed mucoid colonies on galactose. However, when the double revertant, strain A106-1S (Pts+ Suc+), served as the donor, different results were obtained. In this case all of the Pts+ transductants were Suc+, indicating that the reversion to Suc+ was transducible and had occurred at the suc site closely linked to the site of the Pts+ reversion.
Similar results were obtained with another double revertant (strain A107-1S) that had been selected first on mannitol and then on succinate. However, contrasting observations were made with double revertants that had been selected first on succinate and then on mannitol. In all of these cases (strains A106-11M, A106-13M, and A107-12M) the Suc+ phenotype failed to be transduced with the Pts+ reversion, indicating that these reversions to the Suc + phenotype had not occurred at the suc locus and therefore were the result of suppressor mutations. In some cases (e.g., strains MM6-1S and MM6-1SA), even when the double revertants were first selected on mannitol and then on succinate, reversion to the Suc+ phenotype apparently occurred at a suppressor locus not linked to the pts region.
Mapping of suppressors of Suc phenotype.
Since addition of cAMP to the growth medium of strains A106 and MM6 can reverse the Sucphenotype of these strains, it seemed possible that alterations in cAMP metabolism in these cells could also reverse the Suc-phenotype. It follows from this reasoning that genetic suppressors of the Suc-phenotype might be mutations affecting cAMP metabolism. One potential site of such mutations would be the crp gene that codes for the cAMP binding protein. Since crp is linked to strA, we examined whether our Suc+ suppressors mapped in this region of the E. coli chromosome. To do this, phage P1 grown on Suc+ SMR revertants (A106-11M, A106-13M, and A107-12M) were used to transduce a Suc-SMS strain, A230 (ptsIL3), to the ability to grow on succinate (Table 7) . In each case some of the suc+ transductants were also streptomycin resistant, a property indicating that the succinate reversions in these donors are linked to strA. Further evidence for this conclusion was obtained when these transductions were carried out with selection for streptomycin resistance rather than for growth on succinate. Under these conditions, some of the streptomycinresistant transductants obtained with each of the three donors were succinate positive. These results clearly show that the suc+ suppressor in these three strains (A106-11, A106-13, and A107-12) is linked to strA.
The Suc-colonies of strain A230 were mucoid when grown on galactose, whereas the Suc+ transductants were nonmucoid (Table 7) . It is of interest that the suppressors originating in strain A106 suppressed both succinate negativ-ity and mucoidy on galactose in strain A230 since the specific ptsI mutation in A230 was different from that in A106.
Mapping of other succinate revertants is presented in Table 8 . Applying here the same rationale used for interpreting the data in Table  7 , we conclude that the Suc+ suppressor in strain MM6-13 is also linked to str. However, it appears that the suc+ suppressors in two other strains, MM6-12 and MM6-1SA, are not linked to strA or to ptsL Therefore we assume that these strains represent another class of suppressor mutations. DISCUSSION Previous studies (7, 8) have indicated that mutations in the ptsI gene can alter the cell's ability to utilize both PTS sugars such as mannitol, fructose, and mannose and also non-PTS compounds such as glycerol, lactose, maltose, and melibiose. In this study we have examined the ability of ptsI mutants to utilize succinate, a compound that is not known to be phosphorylated by the PTS enzymes.
A set of isogenic strains, which differed only with respect to the ptsI locus, was prepared by transduction. All the strains carrying a ptsI lesion failed to grow on mannitol, fructose, and mannose, as expected since these compounds must be transported and phosphorylated by the PTS system for efficient utilization by the cell. However, these strains, containing four independent lesions (including a small deletion) in the ptsI region, were also impaired for growth on succinate, a non-PTS compound. This observation strongly indicates that lack of growth on succinate is a direct result of impaired function of the ptsI gene product, enzyme I. This idea is supported by the observation that reversion of the simple ptsI point mutations in strains A211 and A240, by selecting for the Pts+ phenotype, simultaneously restored the Pts+ and Suc+ phenotypes. These results extend the observations of Wang et al. (11) 124, 1975 on January 18, 2018 by guest http://jb.asm.org/ differed dramatically from other ptsI mutations in our collection. We were never able to revert strain MM6 (Pts-Suci) by a single selection to the wild-type phenotype, although the wildtype phenotype could be recovered after two separate reversions or by transduction with phage P1 grown on a wild-type donor. When the pts "lesion" of strain MM6 was moved by transduction into the same strain background as the other pts mutations, this.new Pts-Sucstrain (A106) behaved identically to strain MM6 with respect to reversion characteristics.
The simplest explanation for these observations is that strains MM6 and A106 contain two closely linked mutations that both contribute to their Pts-Suc-phenotypes. Since reversion of these strains to the Pts+ phenotype yields Succells, we envisage that strain MM6 contains a mutation in a region suc that is distinct from the mutation identified as ptsI6, which affects enzyme I activity toward PTS sugars. In the transductions reported in Table 5 and on strain A106, this suc region has apparently been separated genetically, at a very low frequency, from the ptsI mutation ptsI6, which affects growth on PTS sugars.
Although we can generate Pts+ Suc-revertants of the doubly negative (Pts-Suc-) strains MM6 and A106 by reversions at the ptsI site, we have never been able to generate Pts-Suc+ derivatives of these strains by a reversion located on the chromosome near the pts region. In other words, all Pts -Suc + revertants of these strains are the result of unlinked suppressor mutations; in all of these Pts-Suc+ revertants the original pts-linked mutations can be recovered by transduction.
This observation leads us to speculate that each of the two pts-linked mutations in strains ptsI6 and suc-1 results in the Suc-phenotype. Clearly, if this were the case the simplest method of restoring the Suc+ phenotype would be through third-site mutations that phenotypically suppress the Suc-character established independently by each of the pts-linked mutations, ptsI6 and suc-1.
This idea is supported by the following observation. Although strains such as MM6 and A106 carrying both the ptsI and suc-1 mutations only acquire the Suc+ phenotype by suppressor mutations, Pts+ strains such as MM6-1 carrying only the suc-1 mutation became Suc+ not only from unlinked suppressor mutations but also from reversions that are tightly linked to ptsI, presumably at suc-1.
Thus we suggest that the pts "lesion" in strain MM6 is actually the result of two very tightly linked mutations, one in ptsI that affects enzyme I activity toward PTS sugars and also elicits the Suc-phenotype, and another in a region which we call suc that does not affect the cell's growth on PTS sugars but impairs growth on succinate. At this time we do not know whether this suc-1 mutation defines a new gene near ptsI or whether it falls within the ptsI gene in a region of the gene that dictates a part of enzyme I structure and activity involved in regulating cell growth on non-PTS compounds.
The results of this study clearly focus attention on one of the most intriguing questions about the PTS system: why do mutations affecting enzyme I activity alter the cell's ability to grow on non-PTS compounds. In addition, these results raise the possibility that in E. coli there exists another gene, identified by the suc-1 mutation, which is tightly linked to the pts loci, far distant on the E. coli chromosome from genes previously known to be involved in succinate transport and metabolism, and capable of altering the cell's ability to utilize succinate as a source of carbon.
Saier and Roseman (8) have studied the physiological effects of pts mutations on the growth of Salmonella typhimurium. Their results have led them to speculate that pts mutations alter the cell's ability to utilize non-PTS compounds by two different mechanisms: first, by decreasing the level of intracellular cAMP, and second, by decreasing the rate at which non-PTS compounds are transported across the cell membrane. However, no evidence directly supporting these views has been presented. Dahl et al. (2) have measured the levels of cAMP in strains of E. coli carrying two independent mutations affecting enzyme I activity, but they have found that one of these mutants has lower levels of intracellular cAMP than the parental strain while the other mutant does not.
We feel that analysis of the Suc+ suppressor mutants we have isolated may aid in deducing the mechanism by which pts mutations affect cell growth on non-PTS compounds. For example, the Suc+ suppressors that we have mapped near the strA locus may well be in the cAMP binding protein. If this is so, it is clear evidence that changes in cellular cAMP metabolism of pts mutants can alter their ability to grow on non-PTS compounds. Work is in progress to characterize more of these Suc+ suppressor mutations, many of which have pleiotropic effects on cell growth on other non-PTS compounds.
But, even with this tool for analyzing the mechanism by which pts mutations affect cell growth on non-PTS sugars, one must ultimately deal with the problem of cause and effect. It maybe that the pts gene products directly regulate utilization of non-PTS compounds and are directly involved in maintaining intracellular cAMP levels. However, it may be that changes in the structure of pts proteins result in such alterations in memnbrane structure that many membrane-bound proteins no longer function normally. In this case one might expect numerous indirect effects of pts mutations on cellular metabolism.
